EAM Investors’s CAS Medical Systems, Inc. CASM Stock Holding History

EAM Investors’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-401,244	Closed	-$642K	–	358
2018 Q4	$642K	Sell	401,244 -191	-0%	-$356	0.17%	223
2018 Q3	$915K	Buy	401,435 +1,186	+0.3%	+$2.53K	0.14%	231
2018 Q2	$780K	Buy	+400,249	New	+$597K	0.12%	240

Other funds holding CASM

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

SAM

SignalPoint Asset Management Springfield, Missouri $411M AUM 23.81% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

EAM Investors's CASM Position: Q1 2019 in Review

EAM Investors sold out of CAS Medical Systems, Inc. (CASM) in Q1 2019, closing a stake of 401,244 shares — an estimated $642K sold.

EAM Investors first reported a position in CASM in Q2 2018 and held it in 3 quarters. The position peaked at $915K in Q3 2018. 32 funds tracked by Wall St. Rank hold CASM as of Q1 2019.

EAM Investors reported no remaining CAS Medical Systems, Inc. position as of Q1 2019 after selling out during the quarter.
EAM Investors sold 401,244 CAS Medical Systems, Inc. shares in Q1 2019, an estimated $642K.
EAM Investors first reported a position in CAS Medical Systems, Inc. in Q2 2018 and held it in 3 quarters.
EAM Investors's CAS Medical Systems, Inc. position peaked at $915K in Q3 2018.
32 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q1 2019.

Based on EAM Investors's 13F filing for Q1 2019, filed 13 May 2019.